期刊文献+

噬菌体展示技术在抗体亲和力成熟中的应用进展 被引量:6

Strategies for affinity maturation of antibody using phage display method
下载PDF
导出
摘要 抗体因其高度的特异性在诊断和靶向治疗上一直备受青睐,相关行业发展也是突飞猛进。噬菌体展示技术作为一种抗体库构建技术,不仅可应用于特异性抗体的筛选,也可应用于对已获得的低亲和力抗体进行亲和成熟的研究。该方法主要利用VH和VL的随机重组,能在一定程度上模拟体内抗体亲和力成熟的过程,使噬菌体展示技术在提升抗体亲和力方面拥有许多优势,以下对噬菌体展示技术在亲和力成熟方面的应用进行综述。 Antibodies are favored in the field of diagnosis and targeting medication for their high specificity, therefore, relative industries grow rapidly. As a library construct technology of antibodies, phage display technology can not only be used for the selection of specific antibodies, but also as a technology for affinity maturation of low- affinity antibody. Random recombination of VH and VL is the core of this technology so as to simulate the process of antibody affinity maturation in vivo to some extent. Therefore, there are many advantages of phage display in the improvement of antibody affinity. In this paper, we review the applications of phage display in antibody affinity maturation.
出处 《免疫学杂志》 CAS CSCD 北大核心 2012年第7期628-632,共5页 Immunological Journal
关键词 噬菌体展示 抗体 亲和力成熟 Phage display Antibody Affinity maturation
  • 相关文献

参考文献29

  • 1林周,黎燕,沈倍奋.体外抗体亲和力成熟的几种策略[J].军事医学科学院院刊,2004,28(3):292-294. 被引量:3
  • 2胡晓林,张春明.基因工程抗体亲和力成熟的策略[J].免疫学杂志,2006,22(6):702-704. 被引量:8
  • 3Sheedy C, MacKenzie R, Hall JC. Isolation and affinity mat- uration of hapten- specific antibodies [J]. Biotechnology Advances, 2007,25(4): 333-352.
  • 4Rajpal A, Beyaz N, Haber L, et al. A general method for greatly improving the affinity of antibodies by using combi- natorial libraries[J]. Proc Natl Acad Sci USA, 2005,102(24): 8466-8471.
  • 5Rothe C, Urlinger S, Ltihning C, et al. The human combinatorial antibody library I-IuCAL GOLD combines diversification of all six CDRs according to the natural immune system with a novel display method for efficient selection of high-affinity antibodies[J]. J Mol Biol, 2008, 376(4): 1182-1200.
  • 6Chowdhury PS, Pastan I. Improving antibody affinity by mimicking somatic hypermutation in vitro[J]. Nature, 1999, 17(6): 568-572.
  • 7McCall AM, Shahied L, Amoroso AR, et al. Increasing the affinity for tumor antigen enhances bispecific antibody cytotoxicity[J]. J Immunol, 2001, 166(10): 6112- 6117.
  • 8Barderas R, Desme J. Affinity maturation of antibodies assisted by in silico modeling[J]. Proc Natl Acad Sci, 2008, 105(26): 9029-9034.
  • 9Lowe 1 DC, Gerhardt S, Ward A, et al. Engineering a high- affinity anti-IL-15 antibody: crystal structure reveals an α- helix in VH CDR3 as key component of paratope[J]. J Mol Biol, 2011, 406(1): 160-175.
  • 10Lu D, Shen J, Vil MD, et al. Tailoring in vitro selection for a picomolar affinity human antibody directed against vas-cular endothelial growth factor receptor 2 for enhanced neutralizing activity[J]. J Biochem, 2003, 278(44): 43496- 43507.

二级参考文献29

  • 1卢筱华,杨冬华,周旻,汤绍辉.抗肝癌单链抗体体外亲和力成熟的改造及意义[J].中华肝脏病杂志,2006,14(3):192-195. 被引量:11
  • 2Yang PL,Schultz PG.Mutational analysis of the affinity maturation of antibody 48G7[J].J Mol Biol,1999,294(5):1191-1201.
  • 3Yang WP,Green K,Pinz-Sweeney S,et al.CDR walking mutagenesis for the affinity maturation of a potent human anti-HIV-1 antibody into the picomolar range[J].J Mol Biol,1995,254(3):392-403.
  • 4Rader C,Cheresh DA,Barbas CF 3rd.A phage display approach for rapid antibody humanization:designed combinatorial V gene libraries[J].Proc Natl Acad Sci USA,1998,95(15):8910-8915.
  • 5McCall AM,Shahied L,Amoroso AR,et al.Increasing the affinity for tumor antigen enhances bispecific antibody cytotoxicity[J].J Immunol,2001,166(10):6112-6117.
  • 6Park SG,Lee JS,Choi IH.Affinity maturation of natural antibody using a chain shuffling technique and the expression of recombinant antibodies in Escherichia coli[J].Biochem Biophys Res Commun,2000,275(2):553-557.
  • 7Stemmer WP.Rapid evolution of a protein in vitro by DNA shuffling[J].Nature,1994,370(64):389-391.
  • 8http://www.FDA.gov/cder/approval/index
  • 9Ling MM.Large antibody display libraries for isolation of high-affinity antibodies[J].Comb Chem High Throughput Screen,2003,6(5):421-432.
  • 10Maynard J,Georgiou G.Antibody engineering [J].Annu Rev Biomed Eng,2000,20 (2):339-376.

共引文献9

同被引文献43

  • 1徐容,沈毅臖,邓松华,蔡春晓,陈秋莉,贾建安,王锦红,潘欣,潘卫.噬菌体展示protein A及protein L Ig结合单结构域随机组合文库及Ig亲和筛选[J].生物化学与生物物理进展,2005,32(6):535-543. 被引量:10
  • 2汪保安,陈晓穗,王欲晓,曲佳,周丽君,王琰.通过随机突变提高抗TNF-α单链抗体的亲和力[J].细胞与分子免疫学杂志,2005,21(4):445-448. 被引量:5
  • 3陈记稷,胡智渊,张彦琼,王吉伟.肿瘤血管靶向噬菌体展示肽的研究进展[J].医学分子生物学杂志,2006,3(2):149-152. 被引量:3
  • 4Kronvall G, Jonsson K. Reeeptins: a novel term for an expanding spectrum of natural and engineered microbial proteins with binding properties for mammalian proteins[ J]. J Mol Recognit, 1999, 12 (1): 38-44.
  • 5Atkins K L, Burman J D, Chamberlain E S, et al. S. aureus lgG- binding proteins SpA and Sbi : host specificity and mechanisms of immune complex formation [ J ]. Mol Immunol, 2008, 45 (6) : 1600 - 11.
  • 6Nomellini J F, Duncan G, Dorocicz I R, et al. S-Layer-mediated display of the immunoglobulin G-binding domain of streptococcal protein G on the surface of caulobacter crescentus : development of an immunoactive reagent[ Jl. Appl Environ Microbiol, 2007, 73 (10) : 3245 -53.
  • 7Yang H, Cao J, Li L Q, et al. Evolutional selection of a combina: torial phage library displaying randomly-rearranged various single domains of immunoglobulin (Ig)-binding proteins (IBPs) with four kinds of Ig molecules[ J]. BMC Microbiol,2008 ,8 :137.
  • 8Jiang S H, Wang J F, Xu R, et al. Alternate arrangement of PpL B3 domain and SpA D domain creates synergistic double-site bind- ing to VH3 and Vkappa regions of fab[ J]. DNA Cell Biol,2008, 27(8) : 423 -31.
  • 9Cao J, Chen Q, Zhang H,et al. Novel evolved immunoglobulin (Ig) -binding molecules enhance the detection of IgM against hepa- titis C virus[J]. PLoS One, 2011,6(4) :e18477.
  • 10Rathjen FG, Schachner M. Immunocytological and biochemical characterization of a new neuronal cell surface component (L1 antigen) which is involved in cell adhesion [ J]. EMBO J, 1984, 3 (1): 1-10.

引证文献6

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部